Exploring Pathomechanisms, Novel Targets, and New Interventions of Neurological and Neuropsychiatric Disorders - Volume 2
HUN-REN-SZTE Neuroscience Research Group, Hungarian Research Network, University of Szeged (HUN-REN-SZTE), Danube Neuroscience Research Laboratory, Szeged, HungaryInterests: neurohormones; neuropeptides; tryptophan; kynurenine; psychiatry; neurology; depression; anxiety; dementia; cognition; pain; antidepressant; translational researchSpecial Issues in IMR Press journals
Department of Psychology, University of Turin, Turin, Italy; Center for Studies and Research in Cognitive Neuroscience, Department of Psychology, University of Bologna, Bologna, ItalyInterests: NIBS techniques; TMS; fear learning; prefrontal cortex; heart-rate variability; neuropsychology; mood disorders; stress-related disorders; psychophysiology; neurodegenerative disordersSpecial Issues in IMR Press journals
Dear Colleagues,
Neurological and neuropsychiatric disorders can be at multiple levels, ranging from psychological profiles of cognitive dysfunction and affective disturbance to the elucidation of molecular, cellular, and circuit-based mechanisms that underlie these pathologies. Cutting-edge advances in neuroscience provide powerful tools for characterizing these pathological states, identifying the neural computations involved, and guiding more precise research and therapeutic interventions. Despite significant progress, most neurological and neuropsychiatric disorders still lack effective disease-modifying treatments, underscoring the critical need for innovative and translatable therapeutic approaches.
This Special Issue highlights the latest experimental and translational advances in neurology and neuropsychiatry, emphasizing neural correlates of cognitive impairments and psychiatric disturbances. We cordially invite authors to contribute original research articles focusing on (but not limited to) the following themes:
- Etiology, pathogenesis, and progression mechanisms
- Prophylactic, disease-modifying, and therapeutic interventions including novel targets
- Innovations in drug discovery and development, naturally derived biomedicines, bioactive molecules, and vaccines
- Preclinical in vitro and animal models
- Bench-to-bedside translational research
- Bedside-to-bench translational research
We also welcome comprehensive reviews, systematic reviews, and meta-analyses that synthesize state-of-the-art evidence and chart future directions in this rapidly evolving field.
Masaru Tanaka and Simone Battaglia
Guest Editors
Manuscripts should be submitted via our online editorial system at https://imr.propub.com by registering and logging in to this website. Once you are registered, click here to start your submission. Manuscripts can be submitted now or up until the deadline. All papers will go through peer-review process. Accepted papers will be published in the journal (as soon as accepted) and meanwhile listed together on the special issue website. Research articles, reviews as well as short communications are preferred. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office to announce on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts will be thoroughly refereed through a double-blind peer-review process. Please visit the Instruction for Authors page before submitting a manuscript. The Article Processing Charge (APC) in this open access journal is 2600 USD. Submitted manuscripts should be well formatted in good English.
- Open Access ReviewGlutamate Excitotoxicity: A Key Secondary Injury Mechanism of Traumatic Brain Injury and Spinal Cord InjuryJiamei Hou, Kelena Klippel, Prodip BoseFront. Biosci. (Landmark Ed) 2025, 30(10), 38904; https://doi.org/10.31083/FBL38904(This article belongs to the Special Issue Exploring Pathomechanisms, Novel Targets, and New Interventions of Neurological and Neuropsychiatric Disorders - Volume 2)61Downloads160Views

